Teva and Trump Administration announce intent to reach medicines agreement

  • Teva and the Trump Administration announced plans to pursue an agreement.
  • The proposed agreement concerns affordable medicines and supply chain security for U.S. patients.
  • The announcement does not provide terms or a timeline for reaching the agreement.

Teva and the Trump Administration announced their intent to reach an agreement focused on affordable medicines and supply chain security for patients in the United States. The announcement outlines an intention to negotiate an agreement, but provides no further terms or timeline.

当サイトの情報はAIを用いて生成されており、正確性を保証するものではありません。 参考情報としてご活用ください。